SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cary S. Kart who wrote (638)4/7/1998 6:58:00 PM
From: Mr. Punisher  Read Replies (1) of 998
 
I have come to think that the FDA has decided to approve this drug, although the chances that I am wrong are greater than me being right. My reasons for thinking that are this: Everything was booked for the April 9 meeting--the ballrooms in Bethesda, everything. Now, the FDA has come under considerable pressure to pass this drug. Could they reject this drug now having cancelled a public meeting that would have allowed some patients and their families a forum to at the very least hear the case being made? The most logical thing to do for the FDA if they were leaning against approval would have been to let the advisory panel meeting take place, and then say "Look, nobody thinks this works." The unusual nature of cancelling a meeting like that--I have to wonder if it isn't a prelude to approval. There is a lot of pressure on these people--I wonder if they are yielding. Good luck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News